Home » Topics » Cancer, BioWorld Science

Cancer, BioWorld Science
RSS

Dosing begins in phase I study of AC-220 for AML

April 12, 2007

FDA extends review period for Torisel NDA

April 12, 2007

Synergy seen with verotoxin-1 and monophosphoryl lipid A in mouse fibrosarcoma

April 12, 2007

Novel PARP-1 inhibitor described by Abbott

April 11, 2007

Phase II study of Curaxin CBLC-102 in prostate cancer advances to next stage

April 11, 2007

Phase II trial studies glufosfamide for soft tissue sarcoma

April 11, 2007

Ariad receives FDA feedback on pivotal study of AP-23573 for metastatic sarcoma

April 11, 2007

Erbitux and platinum-based chemotherapy increases survival in SCCHN

April 11, 2007

Amgen updates Vectibix progress

April 11, 2007

Survival benefit for lenalidomide plus low-dose dexamethasone in multiple myeloma

April 11, 2007

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 18, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for June 16, 2026
GLP-1s need technologies for long-term use
BioWorld
For the long-term impact of GLP-1 therapies in obesity to be realized, they must be paired with data and digital tools. While the drugs are effective, challenges...
UTRN gene involved in arthrogryposis, study finds
BioWorld Science
Arthrogryposis multiplex congenita (AMC) is a group of disorders defined by two or more contractures in different body areas; while genes encoding sarcomeric...
mRNA flu vaccine can activate broad germinal center response
BioWorld
On the eve of the June 17 Vaccines and Related Biological Products Advisory Committee (VRBPAC) meeting, which will discuss Moderna Inc.’s mRNA-1010, researchers...